Theravance Inc (NASDAQ:THRX)

16.19
Data as of Oct 01
 -0.90 / -5.27%
Today’s Change
16.15
Today|||52-Week Range
33.53
-43.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.0B

Company Description

Theravance, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It engages in the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial infections and central nervous system/pain. The company was founded by P. Roy Vagelos, Mathai Mammen and George M. Whitesides in November 1996 and is headquartered in South San Francisco, CA.

Contact Information

Theravance, Inc.
901 Gateway Boulevard
South San Francisco California 94080
P:(650) 808-6000
Investor Relations:
(650) 808-4100

Employees

Shareholders

Other institutional48.58%
Individual stakeholders36.76%
Mutual fund holders33.46%

Top Executives

Michael W. AguiarPresident, CEO, CFO & Director
Frank C. PasqualoneSenior Vice President-Operations
Edmund J. MoranVice President-Research & Development
Junning LeeVice President-Technical Operations
Steven L. BarriereVice President-Clinical & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.